MARSH & MCLENNAN COS

Marsh & Mclennan’s steady 0.08% gain belies a resilient strategy: risk‑analysis, global reach and AI‑powered consulting keep it above valuation peers, rewarding patient investors.

Marsh & McLennan’s steady 0.08% uptick, $90B valuation, and diversified risk‑management portfolio suggest a gradual, stable growth outlook for investors.